Gender and glaucoma: What we know and what we need to know

Current Opinion in Ophthalmology

Volumn 21, Issue 2, 2010, Pages 91-99

  Vajaranant, Thasarat S ^a   Nayak, Sushma ^a   Wilensky, Jacob T ^a   Joslin, Charlotte E ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Blindness; Female sex hormone; Gender difference; Glaucoma; Women health

Indexed keywords

ESTROGEN; SEX HORMONE; TESTOSTERONE;

BLINDNESS; CLOSED ANGLE GLAUCOMA; ETHNICITY; HEALTH BELIEF; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; LONGEVITY; MORBIDITY; OPEN ANGLE GLAUCOMA; OPTIC NERVE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; SOCIOECONOMICS;

FEMALE; GLAUCOMA; HUMANS; INCIDENCE; MALE; PREVALENCE; RISK FACTORS; SEX FACTORS; WOMEN'S HEALTH;

EID: 76949109187     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3283360b7e     Document Type: Review

References (49)

1. Higginbotham EJ. Does sex matter in glaucoma? Arch Ophthalmol 2004; 122:374-375.
2. Hulsman CA, Westendorp IC, Ramrattan RS. Is open-angle glaucoma associated with early menopause? The Rotterdam study. Am J Epidemiol 2001; 154:138-144.
3. Mark HH. Gender differences in glaucoma and ocular hypertension. Arch Ophthalmol 2005; 123:284; author reply 284.
4. Amerasinghe N, Aung T. Angle-closure: risk factors, diagnosis and treatment. Prog Brain Res 2008; 173:31-45.
5. Cedrone C, Mancino R, Cerulli A. Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects. Prog Brain Res 2008; 173:3-14.
6. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90:262-267.
7. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 2001; 131:699-708.
8. Lavanya R, Wong TY, Friedman DS. Determinants of angle closure in older Singaporeans. Arch Ophthalmol 2008; 126:686-691.
9. Casson RJ, Baker M, Edussuriya K. Prevalence and determinants of angle closure in central Sri Lanka: the Kandy Eye study. Ophthalmology 2009; 116:1444-1449; Epub 2009 Jun 26.
10. Van Rens GH, Arkell SM, Charlton W, Doesburg W. Primary angle-closure glaucoma among Alaskan Eskimos. Doc Ophthalmol 1988; 70 (2-3):265-276.
11. Seah SK, Foster PJ, Chew PT. Incidence of acute primary angle-closure glaucoma in Singapore. An island-wide survey. Arch Ophthalmol 1997; 115:1436-1440.
12. Teikari J, Raivio I, Nurminen M. Incidence of acute glaucoma in Finland from 1973 to 1982. Graefes Arch Clin Exp Ophthalmol 1987; 225:357-360.
13. Tielsch JM, Sommer A, Katz J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991; 266:369-374.
14. Klein BE, Klein R, Sponsel WE. Prevalence of glaucoma. The Beaver Dam Eye study. Ophthalmology 1992; 99:1499-1504.
15. Mitchell P, Smith W, Attebo K. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye study. Ophthalmology 1996; 103:1661-1669. (Pubitemid 26357144)
16. Quigley HA, West SK, Rodriguez J. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto Ver. Arch Ophthalmol 2001; 119:1819-1826.
17. Leibowitz HM, Krueger DE, Maunder LR. The Framingham Eye study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980; 24 (Suppl):335-610.
18. Dielemans I, Vingerling JR, Wolfs RC. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam study. Ophthalmology 1994; 101:1851-1855.
19. de Voogd S, Ikram MK, Wolfs RC. Incidence of open-angle glaucoma in a general elderly population: the Rotterdam study. Ophthalmology 2005; 112:1487-1493. (Pubitemid 41725401)
20. Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye study. Prevalence of open angle glaucoma. Arch Ophthalmol 1994; 112:821-829.
21. Leske MC, Wu SY, Hennis A. Risk factors for incident open-angle glaucoma: the Barbados Eye studies. Ophthalmology 2008; 115:85-93; Epub 2007 Jul 16.
22. Varma R, Ying-Lai M, Francis BA. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye study. Ophthalmology 2004; 111:1439-1448. (Pubitemid 39030793)
23. Doshi V, Ying-Lai M, Azen SP. Sociodemographic, family history, and lifestyle risk factors for open-angle glaucoma and ocular hypertension. The Los Angeles Latino Eye study. Ophthalmology 2008; 115:639-647.2e; Epub 2007 Sep 27.
24. Rudnicka AR, Mt-Isa S, Owen CG. Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci 2006; 47:4254-4261.
25. Friedman DS, Wolfs RC, O'Colmain BJ. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol 2004; 122:532-538.
26. Ryskulova A, Turczyn K, Makuc DM. Self-reported age-related eye diseases and visual impairment in the United States: results of the 2002 National Health Interview Survey. Am J Public Health 2008; 98:454-461; Epub 2008 Jan 30..
27. Rodriguez J, Sanchez R, Munoz B. Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology 2002; 109:737-743.
28. Resnikoff S, Pascolini D, Etya'ale D. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82:844-851; Epub 2004 Dec 14.
29. Abou-Gareeb I, Lewallen S, Bassett K, Courtright P. Gender and blindness: a meta-analysis of population-based prevalence surveys. Ophthal Epidemiol 2001; 8:39-56.
30. Congdon N, O'Colmain B, Klaver CC. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122:477-485. (Pubitemid 38456282)
31. Lee AJ, Mitchell P, Rochtchina E. Female reproductive factors and open angle glaucoma: the Blue Mountains Eye study. Br J Ophthalmol 2003; 87:1324-1328.
32. Pasquale LR, Rosner BA, Hankinson SE, Kang JH. Attributes of female reproductive aging and their relation to primary open-angle glaucoma: a prospective study. J Glaucoma 2007; 16:598-605.
33. Nirmalan PK, Katz J, Robin AL. Female reproductive factors and eye disease in a rural South Indian population: the Aravind Comprehensive Eye Survey. Invest Ophthalmol Vis Sci 2004; 45:4273-4276.
34. Pé rez-Ló pez FR, Chedraui P,Gilbert JJ, Pé rez-RonceroG. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era. Fertil Steril 2009; 2:1171-1186.
35. AltintaşO, Caglar Y, Yüksel N. The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow. Ophthalmologica 2004; 218:120-129.
36. Sator MO, Akramian J, Joura EA. Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy. Maturitas 1998; 29:93-95.
37. Sator MO, Joura EA, Frigo P. Hormone replacement therapy and intraocular pressure. Maturitas 1997; 28:55-58.
38. Ogueta SB, Schwartz SD, Yamashita CK, Farber DB. Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 1999; 40:1906-1911.
39. Toker E, Yenice O, Akpinar I. The influence of sex hormones on ocular blood flow in women. Acta Ophthalmol Scand 2003; 81:617-624.
40. Harris A, Harris M, Biller J. Aging affects the retrobulbar circulation differently in women and men. Arch Ophthalmol 2000; 118:1076-1080.
41. Harris-Yitzhak M,HarrisA, Ben-Refael Z. Estrogen-replacement therapy: effects on retrobulbar hemodynamics. Am J Ophthalmol 2000; 129:623-628.
42. Atalay E, Karaali K, Akar M. Early impact of hormone replacement therapy on vascular hemodynamics detected via ocular colour Doppler analysis. Maturitas 2005; 50:282-288.
43. Battaglia C, Mancini F, Regnani G. Hormone therapy and ophthalmic artery blood flow changes in women with primary open-angle glaucoma. Menopause 2004; 11:69-77.
44. Atilla H, Arslanpençe A, Batioǧlu F. Effect of hormone replacement therapy on ocular hemodynamics in postmenopausal women. Eur J Ophthalmol 2001; 11:277-280.
45. Russo R, Cavaliere F, Watanabe C. 17Beta-estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog Brain Res 2008; 173:583-590.
46. Zhou X, Li F, Ge J. Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma. Dev Neurobiol 2007; 67:603-616.
47. de Voogd S, Wolfs RC, Jansonius NM. Estrogen receptors alpha and beta and the risk of open-angle glaucoma: the Rotterdam Study. Arch Ophthalmol 2008; 126:110-114.
48. Warnecke RB, Breen N, Gehlert, et al. Approaching health disparities from a population perspective: the National Institutes of Health Centers for population health and disparities. Am J Public Health 2008; 98:1608-1615.
49. Friedman DS, Nordstrom B, Mozaffari E, Quigley HA. Variations in treatment among adult-onset open-angle glaucoma patients. Ophthalmology 2005; 112:1494-1499.